Form 4: AMN Healthcare Officer's Routine Stock Vesting

Sentiment:

Insider Transaction Report


AMN Healthcare's Chief Information and Digital Officer, Mark Hagan, reported the routine vesting of Restricted Stock Units and subsequent tax-related share disposition.

Summary

  • Mark Christopher Hagan, Chief Information and Digital Officer of AMN Healthcare Services Inc., reported transactions on October 15, 2025.
  • Acquired 9,330 shares of Common Stock through the vesting of Restricted Stock Units (RSUs) at a price of $0.
  • Disposed of 3,339 shares of Common Stock at a price of $20.69 to cover tax obligations related to the RSU vesting.
  • Following these transactions, beneficial ownership of Common Stock is 38,699 shares.
  • Beneficial ownership of derivative securities (Restricted Stock Units) is 9,331 units.
  • The RSUs were granted on October 15, 2024, under the AMN Healthcare 2017 Equity Plan and vest in two tranches on the first and second anniversaries of the grant date.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the vesting of equity compensation and subsequent tax-related share disposition. This is a neutral event, reflecting standard executive compensation practices rather than new operational or financial performance.

Positives

  • The vesting of 9,330 Restricted Stock Units represents earned compensation for the Chief Information and Digital Officer, Mark Hagan.

Negatives

  • 3,339 shares of Common Stock were disposed of to cover tax liabilities, reducing the officer's direct shareholding.

Future Outlook

The Restricted Stock Units granted on October 15, 2024, are scheduled to vest in two tranches on the first and second anniversaries of the grant date, indicating future share acquisitions for the reporting person.

Industry Context

This filing reflects a routine compensation event for an executive in the healthcare staffing and solutions industry. Such equity-based compensation is a common practice across various industries to align executive incentives with shareholder interests.

Stakeholder Impact

  • Shareholders: The transaction is a routine compensation event and does not indicate a change in company fundamentals or strategy. It slightly increases the public float through the vesting of shares, though a portion is withheld for taxes.
  • Employees: Reflects the company's ongoing use of equity compensation plans for executives.

Next Steps

  • The remaining Restricted Stock Units granted on October 15, 2024, are expected to vest in a second tranche on the second anniversary of the grant date.

Key Dates

DateDescription
10/15/2024Grant date of the Restricted Stock Units.
10/15/2025Transaction date for the vesting of Restricted Stock Units and subsequent share disposition for tax purposes.
10/16/2025Signature date of the reporting person.

Recommendation

hold

This Form 4 filing details a routine, pre-scheduled insider transaction involving the vesting of Restricted Stock Units and subsequent tax-related share disposition. It does not provide new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Investors should consider this a standard compensation event for an executive.

Keywords

AMN Healthcare, AMN, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Stock Compensation, Officer Stock Activity, Mark Hagan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.